Literature DB >> 3415213

Concentrations of flucloxacillin in heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgery.

U Frank1, E Schmidt-Eisenlohr, V Schlosser, G Spillner, M Schindler, F D Daschner.   

Abstract

Thirty-seven patients were given a single, 2-g intravenous bolus injection of flucloxacillin prior to open-heart surgery. Within 12 h, flucloxacillin concentrations in serum and heart valves declined from 125.2 to 4.4 micrograms/ml and from 16.5 to 3.7 micrograms/g, respectively. Concentrations in subcutaneous tissue and muscle were almost identical, declining from 14.7 or 14.2 micrograms/g to undetectable levels after 8 to 10 h.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3415213      PMCID: PMC172310          DOI: 10.1128/AAC.32.6.930

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Stomaching: a new concept in bacteriological sample preparation.

Authors:  A N Sharpe; A K Jackson
Journal:  Appl Microbiol       Date:  1972-08

2.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

3.  Penetration of ceftazidime into heart valves and subcutaneous and muscle tissue of patients undergoing open-heart surgery.

Authors:  U Frank; I Kappstein; E Schmidt-Eisenlohr; V Schlosser; G Spillner; M Schindler; F D Daschner
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

4.  Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin.

Authors:  R Sutherland; E A Croydon; G N Rolinson
Journal:  Br Med J       Date:  1970-11-21

5.  Extravascular penetration of highly protein-bound flucloxacillin.

Authors:  T Bergan; A Engeset; W Olszewski; N Ostby; R Solberg
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

6.  Flucloxacillin concentration in serum and wound exudate during open heart surgery.

Authors:  M Farrington; A Fenn; I Phillips
Journal:  J Antimicrob Chemother       Date:  1985-08       Impact factor: 5.790

7.  Pharmacokinetics of vancomycin in serum and tissue of patients undergoing open-heart surgery.

Authors:  F D Daschner; U Frank; A Kümmel; E Schmidt-Eisenlohr; V Schlosser; H Spillner; B Schuster; M Schindler
Journal:  J Antimicrob Chemother       Date:  1987-03       Impact factor: 5.790

  7 in total
  4 in total

1.  Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.

Authors:  J M Entenza; J Vouillamoz; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Penetration of teicoplanin into heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgery.

Authors:  U K Frank; E Schmidt-Eisenlohr; D Mlangeni; M Schindler; A Hoh; F Beyersdorf; F D Daschner
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

3.  In vivo effect of flucloxacillin in experimental endocarditis caused by mecC-positive staphylococcus aureus showing temperature-dependent susceptibility in vitro.

Authors:  Stefano Mancini; Frédéric Laurent; Tiago R Veloso; Marlyse Giddey; Jacques Vouillamoz; François Vandenesch; Philippe Moreillon; José M Entenza
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

4.  Pharmacodynamics of Flucloxacillin in a Neutropenic Murine Thigh Infection Model: A Piece of the Puzzle towards Evidence-Based Dosing.

Authors:  Eveline E Roelofsen; Brenda C M de Winter; Heleen van der Spek; Susan Snijders; Birgit C P Koch; Sanne van den Berg; Anouk E Muller
Journal:  Antibiotics (Basel)       Date:  2022-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.